StonvexLoading…
StonvexCore line items from ACCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $410.58M | $343.70M | $1.52B | $1.10B | $712.20M |
Operating Income | Not available | $-10.40M | $92.30M | $52.30M | $26.30M |
Net Income | Not available | $19.40M | $41.30M | $20.00M | $29.20M |
EPS (Diluted) | $0.27 | $0.20 | $0.44 | $0.21 | $0.17 |
Total Assets | Not available | $2.28B | $2.25B | $2.26B | $2.38B |
Total Liabilities | Not available | $1.60B | $1.59B | $1.61B | $1.74B |
Cash & Equivalents | Not available | $118.90M | $64.40M | $82.50M | $133.30M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 92.30M | 90.14M | 90.10M | 90.10M |